The Geriatric Crisis: Ovarian Cancer in Elderly Patients
Ovarian cancer is a brutal disease that typically requires massive, physically devastating abdominal surgery and highly toxic platinum chemotherapy. When the patient is 80 years old, the treatment is often more lethal than the tumor. Ovarian Cancer in Elderly Patients is a fiercely pragmatic, brutally honest clinical manual detailing exactly how to navigate this impossible scenario. This volume provides the precise oncological and geriatric blueprints required to treat the cancer without killing the fragile patient.
Mastering the Comprehensive Geriatric Assessment (CGA)
The core philosophy of this text is biological age versus chronological age. The authors aggressively detail the mechanics of the frailty index. It dictates exactly how an oncologist must use the CGA to objectively prove whether an 82-year-old woman possesses the physiological reserves to survive a radical cytoreductive surgery, or whether taking her to the operating room will mathematically guarantee a fatal post-operative complication.
Navigating the Carboplatin Compromise
The book provides a masterclass in pharmacological de-escalation. It dictates the exact clinical pathways for modified chemotherapy. It rigorously explores the terrifying reality that standard-dose Paclitaxel will cause irreversible, crippling neuropathy in an elderly patient, detailing the exact mathematical formulas required to reduce the chemotherapy dose so that it suppresses the tumor while allowing the patient to maintain their basic independence.
Frequently Asked Questions (FAQs)
Does this book focus on preserving fertility in young women with ovarian cancer?
No, its absolute, exclusive focus is on the *geriatric oncology, modified pharmacology, and palliative care* required for the elderly patient population.
Who is the primary audience?
It is the absolute, mandatory clinical guide for Gynecologic Oncologists, Medical Oncologists, Geriatricians, and Palliative Care Physicians.
